Sign In
Buy RXST
$4.79
-0.150 (-3.04%)
At Close: Jun 03, 2026
RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
04:05pm, Wednesday, 14'th Feb 2024
ALISO VIEJO, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following
3 Stocks to Buy BEFORE They Become Household Names
03:16pm, Friday, 12'th Jan 2024
Steve Symington is a long-time contributor to The Motley Fool. Over the years, he's written more than 8,000 articles for the publication.
RxSight, Inc. (RXST) Just Overtook the 20-Day Moving Average
07:36pm, Tuesday, 09'th Jan 2024
RxSight, Inc. (RXST) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, RXST crossed above the 20-day moving average, suggesting
ALISO VIEJO, Calif., Jan. 07, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery,
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
04:05pm, Wednesday, 27'th Dec 2023
ALISO VIEJO, Calif., Dec. 27, 2023 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery,
RxSight, Inc. (RXST) Recently Broke Out Above the 50-Day Moving Average
10:32am, Wednesday, 15'th Nov 2023
After reaching an important support level, RxSight, Inc. (RXST) could be a good stock pick from a technical perspective. RXST surpassed resistance at the 50-day moving average, suggesting a short-term
RxSight, Inc. (RXST) Q3 2023 Earnings Call Transcript
04:19am, Sunday, 12'th Nov 2023
RxSight, Inc. (NASDAQ:RXST ) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants Alex Huang - Director, Investor Relations Ron Kurtz - President and Chief Executive Offic
RxSight, Inc. Educational and Product Announcements for AAO 2023
09:00am, Thursday, 02'nd Nov 2023
ALISO VIEJO, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- November 2, 2023 – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients follow
RxSight: Losing Altitude Despite 'Best Of Breed' Platform
11:12am, Friday, 27'th Oct 2023
Today we look at RxSight, Inc., a small ocular focused medical device company focused on transforming the cataract surgery market. The company is delivering 70% year-over-year revenue growth and rapid
Trading The Top-Performing AI Companies From The Small Cap Universe
11:52am, Monday, 23'rd Oct 2023
Small-cap tech stocks have been overshadowed by mega-cap tech giants despite their potential for innovation and future growth. Smaller-cap stocks have appeal for potential acquisition by larger corpor
RxSight, Inc. (RXST) Crossed Above the 20-Day Moving Average: What That Means for Investors
11:17am, Thursday, 07'th Sep 2023
After reaching an important support level, RxSight, Inc. (RXST) could be a good stock pick from a technical perspective. RXST surpassed resistance at the 20-day moving average, suggesting a short-term
RxSight, Inc. to Present at the Wells Fargo Healthcare Conference
04:05pm, Wednesday, 23'rd Aug 2023
ALISO VIEJO, Calif., Aug. 23, 2023 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery,
RxSight, Inc. (RXST) Reports Q2 Loss, Tops Revenue Estimates
07:39pm, Monday, 07'th Aug 2023
RxSight, Inc. (RXST) came out with a quarterly loss of $0.40 per share versus the Zacks Consensus Estimate of a loss of $0.47. This compares to loss of $0.50 per share a year ago.
RxSight, Inc. to Report Second Quarter Financial Results on August 7, 2023
04:05pm, Tuesday, 25'th Jul 2023
ALISO VIEJO, Calif., July 25, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients followin
Strength Seen in RxSight, Inc. (RXST): Can Its 9.6% Jump Turn into More Strength?
09:57am, Friday, 30'th Jun 2023
RxSight, Inc. (RXST) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near ter
